Liminatus pharma, inc. class a common stockLIMN.US Overview

US StockHealthcare

(No presentation for LIMN)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

LIMN Overall Performance

LIMN AI Analysis & Strategy

LIMN Recent Performance

-6.70%

Liminatus pharma, inc. class a common stock

0.81%

Avg of Sector

-1.14%

S&P500

LIMN PowerScanner

LIMN Key Information

LIMN Valuation Metrics

LIMN Earnings Table

LIMN Profile

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.